Pressrelease 09-02-2018 Anticimex Group today announces the acquisition of Quarantine Treatment Centre (QTC) in Auckland, expanding its operations in New Zealand.
QTC is the leading quarantine treatment provider in New Zealand and adds significant value to the country’s biosecurity.
The acquisition is an excellent fit for our New Zealand operations, strengthening our pest control offerings in Auckland. Flick Anticimex works with prevention and new technology to provide our customers with sustainable solutions. QTC is committed to preventing outbreaks of imported pest infestations with their quarantine treatments. Established in 2001, QTC is an industry-recognised business highly skilled in safeguarding New Zealand’s biosecurity.
Commenting on today’s announcement, Alex Andrievski General Manager Flick Anticimex New Zealand:
“QTC is a great business with a strong reputation for customer service and innovations in the biosecurity quarantine treatments industry. With this acquisition, we enhance our position as the most specialised and innovative Pest Control provider in New Zealand and become a leader in biosecurity quarantine treatments designed to protect the New Zealand environment, economy and human health from newly introduced and harmful organisms. Furthermore, it is a complimentary business to our existing operations which will enable us to build service density in the Auckland region and at the same time develop capability and organic growth in the other New Zealand regions.”
For more information, please contact:
Alex Andrievski, General Manager – New Zealand,
Guido Toepfer, President Pacific Region, email@example.com